Joo Hoon Kim (Chan Kim)

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 21

Top Venues

Cancers

Journal for immunotherapy of cancer

International journal of molecular sciences

Oncoimmunology

CHA University School of Medicine

Korea Advanced Institute of Science and Technology (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

CHA University School of Medicine Mar 01 2020

South Korea

Associate Professor :: Medical Oncology

CHA University School of Medicine Sep 01 2015 - Feb 29 2020

South Korea

Assistant Professor :: Medical Oncology

Yonsei University College of Medicine Mar 01 2014 - Aug 31 2015

South Korea

Clinical Fellow :: Medical Oncology

Education History

Korea Advanced Institute of Science and Technology Feb 01 2010 - Feb 28 2013

South Korea

PHD :: Graduate School of Medical Science and Engineering

Publications

Yun Beom Sang, Chaeryoung Lee, Seul-Gi Kim, Boyoung Lee, Beodeul Kang, Joo Hoon Kim, Hong Jae Chon
Impact of Coronavirus Disease 2019 on Unresectable Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab. Journal of clinical medicine 13 (5) (2024)
Yun Beom Sang, Chaeryoung Lee, Seul-Gi Kim, Boyoung Lee, Beodeul Kang, Joo Hoon Kim, Hong Jae Chon
Impact of Coronavirus Disease 2019 on Unresectable Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab. Journal of clinical medicine 13 (5) (2024)
Eun-Jin Go, Hannah Yang, Wooram Park, Seung Joon Lee, Jun-Hyeok Han, So Jung Kong, Won Suk Lee, Dong Keun Han, Hong Jae Chon, Joo Hoon Kim
Systemic Delivery of a STING Agonist-Loaded Positively Charged Liposome Selectively Targets Tumor Immune Microenvironment and Suppresses Tumor Angiogenesis. Small (Weinheim an der Bergstrasse, Germany) (2023)
Eun-Jin Go, Hannah Yang, Seung Joon Lee, Hyun Gul Yang, Jin A Shin, Won Suk Lee, Hye Seong Lim, Hong Jae Chon, Joo Hoon Kim
PB101, a VEGF- and PlGF-targeting decoy protein, enhances antitumor immunity and suppresses tumor progression and metastasis. Oncoimmunology 12 (1) (2023)
Yun Beom Sang, Hannah Yang, Won Suk Lee, Seung Joon Lee, Seul-Gi Kim, Jaekyung Cheon, Beodeul Kang, Chang Woo Kim, Hong Jae Chon, Joo Hoon Kim
High Serum Levels of IL-6 Predict Poor Responses in Patients Treated with Pembrolizumab plus Axitinib for Advanced Renal Cell Carcinoma. Cancers 14 (23) (2022)
Won Suk Lee, Dong Sung Kim, Jeong Hun Kim, Yoonki Heo, Hannah Yang, Eun-Jin Go, Jin Hyoung Kim, Seung Joon Lee, Byung Cheol Ahn, Jung Sun Yum, Hong Jae Chon, Joo Hoon Kim
Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade. Journal for immunotherapy of cancer 10 (6) (2022)
Yun Beom Sang, Hannah Yang, Won Suk Lee, Seung Joon Lee, Seul-Gi Kim, Jaekyung Cheon, Beodeul Kang, Chang Woo Kim, Hong Jae Chon, Joo Hoon Kim
High Serum Levels of IL-6 Predict Poor Responses in Patients Treated with Pembrolizumab plus Axitinib for Advanced Renal Cell Carcinoma. Cancers 14 (23) (2022)
Yun Beom Sang, Hannah Yang, Won Suk Lee, Seung Joon Lee, Seul-Gi Kim, Jaekyung Cheon, Beodeul Kang, Chang Woo Kim, Hong Jae Chon, Joo Hoon Kim
High Serum Levels of IL-6 Predict Poor Responses in Patients Treated with Pembrolizumab plus Axitinib for Advanced Renal Cell Carcinoma. Cancers 14 (23) (2022)
Seung Joon Lee, Hannah Yang, Woo Ram Kim, Yu Seong Lee, Won Suk Lee, So Jung Kong, Hye Jin Lee, Jeong Hun Kim, Jaekyung Cheon, Beodeul Kang, Hong Jae Chon, Joo Hoon Kim
STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer. Journal for immunotherapy of cancer 9 (6) (2022)
Hyung Soon Park, Yoo Min Kim, Sewha Kim, Won Suk Lee, So Jung Kong, Hannah Yang, Beodeul Kang, Jaekyung Cheon, Su-Jin Shin, Joo Hoon Kim, Hong Jae Chon
High endothelial venule is a surrogate biomarker for T-cell inflamed tumor microenvironment and prognosis in gastric cancer. Journal for immunotherapy of cancer 9 (10) (2022)
Jeong Hun Kim, Won Suk Lee, Hye Jin Lee, Hannah Yang, Seung Joon Lee, So Jung Kong, Soyeon Je, Hyun-Jin Yang, Jongsun Jung, Jaekyung Cheon, Beodeul Kang, Hong Jae Chon, Joo Hoon Kim
Deep learning model enables the discovery of a novel immunotherapeutic agent regulating the kynurenine pathway. Oncoimmunology 10 (1) (2021)
Yu Seong Lee, Won Suk Lee, Chang Woo Kim, Seung Joon Lee, Hannah Yang, So Jung Kong, John Ning, Kyung-Mee Yang, Beodeul Kang, Woo Ram Kim, Hong Jae Chon, Joo Hoon Kim
Oncolytic vaccinia virus reinvigorates peritoneal immunity and cooperates with immune checkpoint inhibitor to suppress peritoneal carcinomatosis in colon cancer. Journal for immunotherapy of cancer 8 (2) (2021)
Chang Woo Kim, Hong Jae Chon, Joo Hoon Kim
Combination Immunotherapies to Overcome Intrinsic Resistance to Checkpoint Blockade in Microsatellite Stable Colorectal Cancer. Cancers 13 (19) (2021)
Ho Jung An, Hong Jae Chon, Joo Hoon Kim
Peripheral Blood-Based Biomarkers for Immune Checkpoint Inhibitors. International journal of molecular sciences 22 (17) (2021)
Won Suk Lee, Hannah Yang, Hong Jae Chon, Joo Hoon Kim
Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity. Experimental & molecular medicine 52 (9) (2020)
Chang-Myung Oh, Hong Jae Chon, Joo Hoon Kim
Combination Immunotherapy Using Oncolytic Virus for the Treatment of Advanced Solid Tumors. International journal of molecular sciences 21 (20) (2020)
Fengjiao Chang, So Jung Kong, Lele Wang, Beom K Choi, Hyewon Lee, Joo Hoon Kim, Jin Man Kim, Kyungpyo Park
Targeting Actomyosin Contractility Suppresses Malignant Phenotypes of Acute Myeloid Leukemia Cells. International journal of molecular sciences 21 (10) (2020)
Eun-Jin Go, Hannah Yang, Hong Jae Chon, DaSom Yang, WonHyoung Ryu, Dong-Hyun Kim, Dong Keun Han, Joo Hoon Kim, Wooram Park
Combination of Irreversible Electroporation and STING Agonist for Effective Cancer Immunotherapy. Cancers 12 (11) (2020)
Hong Jae Chon, Joo Hoon Kim, Arthur Cho, Yoo Min Kim, Su Jin Jang, Bo Ok Kim, Chan Hyuk Park, Woo Jin Hyung, Joong Bae Ahn, Sung Hoon Noh, Mijin Yun, Sun Young Rha
The clinical implications of FDG-PET/CT differ according to histology in advanced gastric cancer. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 22 (1) (2018)
Hong Jae Chon, Won Suk Lee, Hannah Yang, So Jung Kong, Na Keum Lee, Eun Sang Moon, Jiwon Choi, Eun Chun Han, Joo Hoon Kim, Joong Bae Ahn
Tumor Microenvironment Remodeling by Intratumoral Oncolytic Vaccinia Virus Enhances the Efficacy of Immune-Checkpoint Blockade. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (5) (2018)
Yunho Kim, Hye Jin Nam, Junyeop Lee, Do Young Park, Joo Hoon Kim, Young Suk Yu, Dongha Kim, Se Won Park, Jinhyuk Bhin, Daehee Hwang, Ho Lee, Gou Young Koh, Sung Hee Baek
Methylation-dependent regulation of HIF-1α stability restricts retinal and tumour angiogenesis. Nature communications 7 (2016)

Joo Hoon Kim.css-eqlu8i{font-size:small;padding-left:4px;} (Chan Kim)

Publication Activity (10 Years)

Top Topics

Top Venues

Joo Hoon Kim (Chan Kim)